drugset / Trial / NCT01672996
Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers
Phase 1/2
Completed
66 enrolled
GE Healthcare
Physician Reference Laboratory · collabQuintiles, Inc. · collab
RandomizedParallel-groupOpen-labelDiagnostic
Summary
To optimize both the Ioforminol concentration and dosage(s) for CECT of the abdomen. To evaluate the safety and tolerability of low concentration Ioforminol Injections. Study recruits healthy volunteers.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ioforminol | Diagnostic / imaging agent | 160 mg/ml | — |
| Subject | Ioforminol | Diagnostic / imaging agent | 200 mg/ml | — |
| Comparator | Iopamidol | Diagnostic / imaging agent | 300 mg/ml | — |
Indications
No indication recorded.